Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 700 in Lipitor, Atorvastatin (generic)

  1. Judge Sheridan Dismisses More Plaintiffs in Lipitor Antitrust CaseRead the original story w/Photo

    Nov 5, 2014 | jdsupra.com

    Late last week, District Court Judge Peter Sheridan dismissed with prejudice the complaint for antitrust injury by the so-called "End Payor Class Purchasers" against the parties in previous ANDA litigation in the case styled In re Lipitor Antitrust Litigation . The gravamen of the complaint was that the defendants violated Sections 1 and 2 of the Sherman Antitrust Act by entering into a "reverse payment settlement agreement" in that ANDA litigation.

    Comment?

  2. How to Save Money on Health CareRead the original story w/Photo

    Nov 4, 2014 | Kiplinger Online

    No matter how you get your insurance -- through your employer, from a state exchange, from an agent or directly from an insurance company -- you're probably paying a bigger share of your health-care costs than you used to. Premiums and deductibles are on the rise, while provider networks are shrinking.

    Comment?

  3. What are the 25 most prescribed drugs in N.J.?Read the original story w/Photo

    Nov 4, 2014 | The Jersey Journal

    Bottles of Bristol-Myers Squibb Co. Abilify brand medication sits on a pharmacy shelf in Princeton, Illinois.

    Comment?

  4. White Mulberry Tablets Receive Positive Reviews from Users & Prove to ...Read the original story w/Photo

    Nov 4, 2014 | LivePressWorld

    Produced by BioGanix, a brand renowned for manufacturing some of the best health and beauty supplements, White Mulberry tablets have become a strong choice for those looking to alter their lifestyle for the better. 04, November 2014: As a greater number of people have become increasingly health conscious, the use of dietary supplements has increased significantly in the last couple of years.

    Comment?

  5. Airwheel Electric Unicycle Vs ScooterRead the original story

    Nov 4, 2014 | Release News

    Scooter and electric unicycle both have pros and cons. However, in a series of comparisons between them, the latter turns out to be superior.

    Comment?

  6. Twenty Lipitor Lawsuits Dismissed From Federal Diabetes Litigation, Bernstein Liebhard LLP ReportsRead the original story

    Oct 31, 2014 | Personal Injury Law News

    The Firm is investigating potential Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of the cholesterol-lowering statin.

    Comment?

  7. Twenty Lipitor Lawsuits Dismissed From Federal Diabetes Litigation,...Read the original story w/Photo

    Oct 31, 2014 | PRWeb

    The Firm is investigating potential Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of the cholesterol-lowering statin. Our Firm continues to hear from Lipitor patients on a regular basis, all of whom allegedly developed new-onset Type 2 diabetes due to their use of this cholesterol lowering statin.

    Comment?

  8. Synergistic effects of atorvastatin and rosiglitazone on endothelium...Read the original story

    Oct 31, 2014 | Lipids in Health and Disease

    Endothelial dysfunction is implicated in the initiation and progression of atherosclerosis. Whether atorvastatin combined with rosiglitazone has synergistic effects on endothelial function improvement in the setting of dyslipidemia is unknown.

    Comment?

  9. Health-care spending projected to grow at slowest pace in 17 yearsRead the original story w/Photo

    Oct 30, 2014 | The Globe and Mail

    Overall, Canadian health care spending amounted to more than $200-billion in 2012. Of this amount, over $140-billion was financed by federal and provincial tax revenues Overall, Canadian health care spending amounted to more than $200-billion in 2012.

    Comment?

  10. Uganda grapples with access to drugs for Non Communicable Di......Read the original story w/Photo

    Oct 30, 2014 | New Vision

    Kafeero just like others is not aware that one of the risk factors associated with high blood pressure and diabetes is obesity. The country is sitting on a time bomb due an increase of lifestyle diseases known as Non Communicable Diseases .

    Comment?

  11. NIH Study Explores Heart Disease Prevention in HIV PatientsRead the original story

    Oct 29, 2014 | P&T Community

    The National Institutes of Health has launched a clinical trial to assess the effects of aspirin and cholesterol-lowering drugs in preventing cardiovascular disease in individuals with long-term human immunodeficiency virus infections. This group, which includes patients receiving antiretroviral therapy as well as "elite controllers" who can limit the virus without ART, has a higher risk of developing heart disease and stroke compared with the general population.

    Comment?

  12. Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square OffRead the original story w/Photo

    Oct 29, 2014 | The Motley Fool

    Big pharmaceutical companies are in the midst of dealing with the most sweeping patent cliff in their history, and Pfizer over anti-inflammatory drug Enbrel, for instance, which has now ended and has certainly constrained Pfizer's profitability. Similarly, its collaborative revenue for chronic obstructive pulmonary disorder drug Spiriva ended in a number of countries.

    Comment?

  13. Pfizer's third quarter better than expectedRead the original story w/Photo

    Oct 28, 2014 | The Day

    Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection. The New York drugmaker reported third-quarter profit of $2.67 billion, or 42 cents per share, up from $2.59 billion, or 39 cents a share, in the prior-year period.

    Comment?

  14. Current and emerging strategies for the prevention of graft-versus-host disease.Read the original story

    Oct 28, 2014 | CiteULike

    Graft-versus-host disease represents the most serious and challenging complication of allogeneic haematopoietic stem-cell transplantation . New insights on the role of regulatory T-cells, T cells, and antigen-presenting cells have led to an improved understanding of the pathophysiology of GVHD.

    Comment?

  15. Pfizer thrives on emerging market growthRead the original story w/Photo

    Oct 28, 2014 | Salt Lake Tribune

    Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection. The New York drugmaker reported third-quarter profit of $2.67 billion, or 42 cents per share, up from $2.59 billion, or 39 cents a share, in the prior-year period.

    Comment?

  16. Emerging Markets Boost Pfizer Q3Read the original story w/Photo

    Oct 28, 2014 | Hispanic Business

    Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection. The New York drugmaker reported third-quarter profit of $2.67 billion, or 42 cents per share, up from $2.59 billion, or 39 cents a share, in the prior-year period.

    Comment?

  17. Dow 30 Earnings: Pfizer Third Quarter 2014Read the original story

    Oct 28, 2014 | Value Line

    Pfizer , the New York-based drugmaker and a Dow-30 component, has reported third-quarter earnings of $0.42 a share, versus $0.39 in the comparable period of 2013. Year-over-year improvement was driven primarily by sharp cost cutting, offset by lower revenues.

    Comment?

  18. Lipitor Lawsuit Filings Surpass 1,300 Cases in Federal Diabetes...Read the original story w/Photo

    Oct 27, 2014 | PRWeb

    The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of the statin medication. Our Firm continues to hear from Lipitor patients on a fairly regular basis who claim they developed Type 2 diabetes due to their use of this medication.

    Comment?

  19. Dr. Roach: Metal joins in MRIL sleuthing safetyRead the original story w/Photo

    Oct 26, 2014 | SouthCoastToday.com

    DEAR DR. ROACH: I am considering minimally invasive spine surgery. Almost 19 years ago, I had a right total-knee replacement, which still functions very well.

    Comment?

  20. Hormone replacement therapy and statins: what every woman should knowRead the original story w/Photo

    Oct 23, 2014 | Examiner.com

    The objective of the study was to examine the effects of HRT on the risk of cardiovascular outcomes and all-cause mortality in women treated with statins In their menopausal years, many women take statins and/or hormone replacement therapy . A new study evaluated the use of HRT and cardiovascular risk among women under treatment with statins.

    Comment?